Lexaria Bioscience Corp. (NASDAQ: LEXX) on Tuesday provided an update on its Phase 1b, 12-week chronic study GLP-1-H24-4, recently completed in Australia, focusing on 4 DehydraTECH ( DHT) study arms ...
DHT, a hormone derived from testosterone, contributes to the development of male sex characteristics, but can also cause hair follicles to shrink, leading to hair loss. Treatments like finasteride and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results